Cash Dividend On The Way From John Hancock Preferred Income Fund II (HPF)

Looking at the universe of stocks we cover at Dividend Channel, on 10/9/13, John Hancock Preferred Income Fund II (HPF) will trade ex-dividend, for its monthly dividend of $0.14, payable on 10/31/13. As a percentage of HPF's recent stock price of $18.87, this dividend works out to approximately 0.74%, so look for shares of John Hancock Preferred Income Fund II to trade 0.74% lower — all else being equal — when HPF shares open for trading on 10/9/13.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for HPF, showing historical dividends prior to the most recent $0.14 declared by John Hancock Preferred Income Fund II:

HPF+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from HPF is likely to continue, and whether the current estimated yield of 8.90% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of HPF shares, versus its 200 day moving average:

John Hancock Preferred Income Fund II 200 Day Moving Average Chart

Looking at the chart above, HPF's low point in its 52 week range is $17.83 per share, with $24.34 as the 52 week high point — that compares with a last trade of $18.97.

In Monday trading, John Hancock Preferred Income Fund II shares are currently down about 0.3% on the day.

null

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says